Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot study
Authors:
Open Access
- 2 April 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-14
Abstract
In multiple sclerosis (MS), alterations of the gut microbiota lead to inflammation. However, the role of other microbiomes in the body in MS has not been fully elucidated. In a pilot case-controlled study, we carried out simultaneous characterization of faecal and oral microbiota and conducted an in-depth analysis of bacterial alterations associated with MS. Using 16S rRNA sequencing and metabolic inference tools, we compared the oral/faecal microbiota and bacterial metabolism pathways in French MS patients (n = 14) and healthy volunteers (HV, n = 21). A classification model based on metabolite flux balance was established and validated in an independent German cohort (MS n = 12, HV n = 38). Our analysis revealed decreases in diversity indices and oral/faecal compartmentalization, the depletion of commensal bacteria (Aggregatibacter and Streptococcus in saliva and Coprobacter and Roseburia in faeces) and enrichment of inflammation-associated bacteria in MS patients (Leptotrichia and Fusobacterium in saliva and Enterobacteriaceae and Actinomyces in faeces). Several microbial pathways were also altered (the polyamine pathway and remodelling of bacterial surface antigens and energetic metabolism) while flux balance analysis revealed associated alterations in metabolite production in MS (nitrogen and nucleoside). Based on this analysis, we identified a specific oral metabolite signature in MS patients, that could discriminate MS patients from HV and rheumatoid arthritis patients. This signature allowed us to create and validate a discrimination model on an independent cohort, which reached a specificity of 92%. Overall, the oral and faecal microbiomes were altered in MS patients. This pilot study highlights the need to study the oral microbiota and oral health implications in patients with autoimmune diseases on a larger scale and suggests that knowledge of the salivary microbiome could help guide the identification of new pathogenic mechanisms associated with the microbiota in MS patients.Keywords
Funding Information
- Notresclérose
- Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques
- Conseil Régional des Pays de la Loire (LOIRE-TIMES)
- U.S. Department of Veterans Affairs (I01BX002625)
This publication has 56 references indexed in Scilit:
- Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and courseCell, 2022
- Formaldehyde and Brain Disorders: A Meta-Analysis and Bioinformatics ApproachNeurotoxicity Research, 2021
- Oral Colonization by Candida Species in Patients with Multiple SclerosisMycopathologia, 2020
- Dysbiosis of oral microbiota is associated with systemic lupus erythematosusArchives of Oral Biology, 2020
- Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypesAnnals of Clinical and Translational Neurology, 2020
- Inosine improves cognitive function and decreases aging-induced oxidative stress and neuroinflammation in aged female ratsInflammopharmacology, 2018
- Permutational Multivariate Analysis of Variance ( PERMANOVA )2017
- Gut Microbiota and Celiac DiseaseDigestive Diseases and Sciences, 2016
- Hypomethylating Agent 5‐Aza‐2′‐deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse ModelsJournal of Cellular Physiology, 2014
- Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunityCell, 1993